These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11276125

  • 21. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG, Voda J, Yu X, McKeon G, Bourdette DN.
    J Neurosci Res; 2004 Aug 01; 77(3):367-77. PubMed ID: 15248293
    [Abstract] [Full Text] [Related]

  • 22. Glutamate excitotoxicity in a model of multiple sclerosis.
    Pitt D, Werner P, Raine CS.
    Nat Med; 2000 Jan 01; 6(1):67-70. PubMed ID: 10613826
    [Abstract] [Full Text] [Related]

  • 23. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H.
    Verh Dtsch Ges Pathol; 1996 Jan 01; 80():109-15. PubMed ID: 9064993
    [Abstract] [Full Text] [Related]

  • 24. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 25. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Apr 30; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 26. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
    De Keyser J, Zeinstra E, Mostert J, Wilczak N.
    Trends Pharmacol Sci; 2004 Feb 30; 25(2):67-71. PubMed ID: 15102491
    [Abstract] [Full Text] [Related]

  • 27. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK, Blakemore WF.
    Brain; 2005 Mar 30; 128(Pt 3):528-39. PubMed ID: 15699059
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice.
    Linker RA, Sendtner M, Gold R.
    J Neurol Sci; 2005 Jun 15; 233(1-2):167-72. PubMed ID: 15949503
    [Abstract] [Full Text] [Related]

  • 29. Differential changes in axonal conduction following CNS demyelination in two mouse models.
    Bando Y, Takakusaki K, Ito S, Terayama R, Kashiwayanagi M, Yoshida S.
    Eur J Neurosci; 2008 Nov 15; 28(9):1731-42. PubMed ID: 18973589
    [Abstract] [Full Text] [Related]

  • 30. Building different mouse models for human MS.
    Bettelli E.
    Ann N Y Acad Sci; 2007 Apr 15; 1103():11-8. PubMed ID: 17376825
    [Abstract] [Full Text] [Related]

  • 31. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 15; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 32. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
    Komoly S.
    Ideggyogy Sz; 2005 Jan 20; 58(1-2):40-3. PubMed ID: 15884397
    [Abstract] [Full Text] [Related]

  • 33. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep 20; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.